Jerusalem’s Hadassah Medical Center has preordered 1.5 million coronavirus vaccines from Russia, where the treatment is still in phase 3 trials but has already been administered to tens of thousands of people, Army Radio reports.
CEO Zeev Rotstein says that the medical center will apply to the Health Ministry this week for permission to eventually use the vaccine in Israel, if the trials in Russia prove it is safe and can prevent infection.
“There is a pretty good probability that the vaccine is safe and a reasonable probability… that it is also effective,” he says, but not the full picture will only be clear when all the data is available at the end of the Russian trial, which is nearing completion.
“The safety results we saw were very good,” he adds.
If all goes well, the vaccine, named Sputnik V, could be available in Israel within two-three months, according to the report.
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
From the Liveblog of
Thursday, November 5, 2020
Add ToI as a Preferred Source on Google
